Nicotine metabolism principally normally takes put in the liver. Consequently, when nicotine is administered through the GI process, it undergoes very first-move metabolism from the liver, resulting in a bioavailability of only about 20%. This process inherently decreases the bioavailability of nicotine throughout the procedure and may induce adver